Skip to main content
Top
Published in: Cardiovascular Toxicology 2/2024

20-02-2024 | Active Ingredients | Research

Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies

Authors: Jingyun Gao, Yueyue Wang, Hui Xiong, Shengnan Zhao, Mingmei He, Meiting He, Haifeng Pan

Published in: Cardiovascular Toxicology | Issue 2/2024

Login to get access

Abstract

Hawthorn leaf has shown therapeutic effects in the patients with myocardial ischemia. Our study combines network pharmacology, molecular docking techniques, and in vitro experiment with the aim of revealing the mechanism of hawthorn leaves in the treatment of myocardial ischemia. The active ingredients and corresponding targets of hawthorn leaf through Traditional Chinese Medicine System Pharmacology and Swiss Target Prediction databases. Targets related to myocardial ischemia were retrieved by Gene Card, Online Mendelian Inheritance in Man, Disgenet, and Therapeutic Targets Database databases. Cytoscape software was used to construct an ingredient–target–organ network and enrichment analysis of common targets was analyzed. Molecular docking verification of the core compound and target interactions was performed using MOE software. In vitro cell experiment was performed to verify the findings from bioinformatics analysis. Six active components and 107 potential therapeutic targets were screened. The protein–protein interaction network analysis indicated that 10 targets, including AKT1 and EGFR, were hub genes. Quercetin, kaempferol and isorhamnetin were taken as core active components. Through pathway enrichment analysis, nearly 455 Gene Ontology entries and 77 Kyoto Encyclopedia of Genes and Genomes pathways were obtained, mainly including PI3K/Akt, estrogen and other signaling pathways. Molecular docking prediction showed that three main active ingredients were firmly combined with the core targets. Cellular experiments showed that quercetin alleviated oxidative damage in cells and regulated the expression of PI3K, P-AKT/AKT and Bax/Bcl-2 proteins. This study identified the potential targets of Hawthorn leaf against myocardial ischemia using network pharmacology and in vitro verification, which provided a new understanding of the pharmacological mechanisms of Hawthorn leaf in treatment of myocardial ischemia.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Pharmacopoeia Commission. (2015). Pharmacopoeia of the people’s republic of China. China Medical Science and Technology Press. National Pharmacopoeia Commission. (2015). Pharmacopoeia of the people’s republic of China. China Medical Science and Technology Press.
5.
go back to reference Zang, Z. Z., Chen, L. M., Liu, Y., Guan, Y. M., Du, Q., Xu, P., Shen, Q., Yang, M., Liu, H. N., & Liao, Z. G. (2021). Uncovering the protective mechanism of the volatile oil of Acorus tatarinowii against acute myocardial ischemia injury using network pharmacology and experimental validation. Evidence-Based Complementary and Alternative Medicine: ECAM, 2021, 6630795. https://doi.org/10.1155/2021/6630795CrossRefPubMed Zang, Z. Z., Chen, L. M., Liu, Y., Guan, Y. M., Du, Q., Xu, P., Shen, Q., Yang, M., Liu, H. N., & Liao, Z. G. (2021). Uncovering the protective mechanism of the volatile oil of Acorus tatarinowii against acute myocardial ischemia injury using network pharmacology and experimental validation. Evidence-Based Complementary and Alternative Medicine: ECAM, 2021, 6630795. https://​doi.​org/​10.​1155/​2021/​6630795CrossRefPubMed
8.
go back to reference Practise Guideline. (2020). For integrated management of cardiovascular diseases in primary hospitals. Chinese Medical Journal, 12(08), 1–73. Practise Guideline. (2020). For integrated management of cardiovascular diseases in primary hospitals. Chinese Medical Journal, 12(08), 1–73.
11.
go back to reference Luo, L., Wang, H., Huang, G., Zhang, L., Li, X., Ma, C., & Wang, X. (2022). Pharmacological mechanisms of Tinglizi against chronic heart failure determined by network pharmacology and molecular docking. Evidence-Based Complementary and Alternative Medicine: ECAM, 2022, 2152399. https://doi.org/10.1155/2022/2152399CrossRefPubMed Luo, L., Wang, H., Huang, G., Zhang, L., Li, X., Ma, C., & Wang, X. (2022). Pharmacological mechanisms of Tinglizi against chronic heart failure determined by network pharmacology and molecular docking. Evidence-Based Complementary and Alternative Medicine: ECAM, 2022, 2152399. https://​doi.​org/​10.​1155/​2022/​2152399CrossRefPubMed
14.
go back to reference Tang, M. (2021). In vitro pharmacodynamic test study of antimyocardial ischemia of Tianxiangdan based on network pharmacology. Xinjiang Medical University. Tang, M. (2021). In vitro pharmacodynamic test study of antimyocardial ischemia of Tianxiangdan based on network pharmacology. Xinjiang Medical University.
15.
go back to reference Li, Y., & Jeon, J. (2013). Quercetin modulates PTEN-Akt pathway to inhibit H2O2-induced apoptosis in vascular endothelial cells. Chinese Journal of Atherosclerosis, 12, 1089–1092. Li, Y., & Jeon, J. (2013). Quercetin modulates PTEN-Akt pathway to inhibit H2O2-induced apoptosis in vascular endothelial cells. Chinese Journal of Atherosclerosis, 12, 1089–1092.
16.
go back to reference An, H. Y. (2016). Huang L j academic thoughts and clinical experience, and restenosis after interventional treatment of the coronary heart disease clinical research. Beijing University of Chinese Medicine. An, H. Y. (2016). Huang L j academic thoughts and clinical experience, and restenosis after interventional treatment of the coronary heart disease clinical research. Beijing University of Chinese Medicine.
17.
go back to reference Hu, S. S. (2021). The writing committee of the report on cardiovascular health and diseases in China. China Cardiovascular Journal, 26(03), 209–218. Hu, S. S. (2021). The writing committee of the report on cardiovascular health and diseases in China. China Cardiovascular Journal, 26(03), 209–218.
20.
go back to reference Editorial board of Chinese Journal of Cardiovascular Diseases. (2019). Expert consensus on early antithrombotic therapy and inter-hospital transport in patients with acute coronary syndrome. Clinical Medical Research and Practice (Chin), 4(18), 201. Editorial board of Chinese Journal of Cardiovascular Diseases. (2019). Expert consensus on early antithrombotic therapy and inter-hospital transport in patients with acute coronary syndrome. Clinical Medical Research and Practice (Chin), 4(18), 201.
21.
go back to reference Ferenczyova, K., Kalocayova, B., Kindernay, L., Jelemensky, M., Balis, P., Berenyiova, A., Zemancikova, A., Farkasova, V., Sykora, M., Tothova, L., Jasenovec, T., Radosinska, J., Torok, J., Cacanyiova, S., Barancik, M., & Bartekova, M. (2020). Quercetin exerts age-dependent beneficial effects on blood pressure and vascular function, but is inefficient in preventing myocardial ischemia-reperfusion injury in Zucker diabetic fatty rats. Molecules (Basel, Switzerland), 25(1), 187. https://doi.org/10.3390/molecules25010187CrossRefPubMed Ferenczyova, K., Kalocayova, B., Kindernay, L., Jelemensky, M., Balis, P., Berenyiova, A., Zemancikova, A., Farkasova, V., Sykora, M., Tothova, L., Jasenovec, T., Radosinska, J., Torok, J., Cacanyiova, S., Barancik, M., & Bartekova, M. (2020). Quercetin exerts age-dependent beneficial effects on blood pressure and vascular function, but is inefficient in preventing myocardial ischemia-reperfusion injury in Zucker diabetic fatty rats. Molecules (Basel, Switzerland), 25(1), 187. https://​doi.​org/​10.​3390/​molecules2501018​7CrossRefPubMed
23.
go back to reference Li, S. S., Li, P., Kang, N., Yuan, J., & Li, J. L. (2021). Research progress on the relationship between PI3K/AKT signaling pathway and cardiovascular disease. Beijing Medicine, 43(01), 66–69. Li, S. S., Li, P., Kang, N., Yuan, J., & Li, J. L. (2021). Research progress on the relationship between PI3K/AKT signaling pathway and cardiovascular disease. Beijing Medicine, 43(01), 66–69.
Metadata
Title
Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies
Authors
Jingyun Gao
Yueyue Wang
Hui Xiong
Shengnan Zhao
Mingmei He
Meiting He
Haifeng Pan
Publication date
20-02-2024
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 2/2024
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-024-09825-w

Other articles of this Issue 2/2024

Cardiovascular Toxicology 2/2024 Go to the issue